DISCLOSURE SUMMARY As a sponsor accredited by the Accreditation Council for Continuing Medical Education, the International Association for the Study of Lung Cancer (IASLC) must insure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All speakers/contributors participating in a sponsored activity are expected to disclose to the accredited provider any significant financial interest or other relationship(s) involving themselves or their spouse/partner within the last 12 months with any proprietary entity producing health care goods or services related to the content of the activity. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making the presentation, but rather to identify and resolve any conflicts of interest that may control the content of the activity. It is also intended that any potential conflict be identified openly so that the listeners have a full disclosure of the facts and may form their own judgments about the presentation. It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion. All other faculty/contributors have reported no commercial affiliation associated with this conference or intent to reference off-label/unapproved uses of products or devices in their presentations. First Name Last Name Nature of Relevant Name of Company(s) Financial Relationship Nivedita Aanur Full-time/part-time Employee BMS Nivedita Aanur Stock Shareholder (directly BMS purchased) A Abbattista Full-time/part-time Employee Pfizer A Abbattista Stock Shareholder (directly Pfizer purchased) Chihiro Abe Full-time/part-time Employee Daiichi Sankyo. Co., Ltd. Amy Abernethy Consultant Roche/Genentech, BMS, Helsinn Amy Abernethy Full-time/part-time Employee Flatiron Health (full time) Ellias Abreu Lima Honoraria Astrazeneca Nacer Abrouk Consultant EpicentRx, Inc Brenda Acevedo Grants/Research Support Acerta Pharma, Bristol-Myers Squibb, Nektar, Celldex, Sanofi, Vascular Biogenics Brenda Acevedo Other (explain): Travel: Vascular Biogenics Joachim Aerts Consultant Amphera bv Joachim Aerts Consultant Lilly Joachim Aerts Grants/Research Support Amphera bv Joachim Aerts Other (explain): Amphera bv Daniel Afar Full-time/part-time Employee AbbVie Daniel Afar Stock Shareholder (directly AbbVie, may own stock purchased) Suresh Agarwal Full-time/part-time Employee Roche Charu Aggarwal Consultant Genentech, Roche Tanya Ahmad Grants/Research Support AstraZeneca, Boehringer Ingelheim, Eli- Lilly, Pfizer 1 Tanya Ahmad Honoraria Boehringer Ingelheim, Neo Oncology Tanya Ahmad Other (explain): Boehringer Ingelheim, MSD, Pfizer, Pierre Fabre Myung-Ju Ahn Consultant AstraZeneca, BMS, Boehringer Ingelheim, MSD, Novartis Hiroaki Akamatsu Honoraria AstraZeneca, Eli Lilly, Chugai Pharmaceuticals, Boehringer Ingelheim, Merck, Pfizer, Ono Pharmaceuticals, Taiho Pharmaceuticals, Novartis Mikhail Akimov Full-time/part-time Employee Novartis Mikhail Akimov Stock Shareholder (directly Novartis purchased) Mahmood Alam Full-time/part-time Employee Pfizer Jordi Alcaraz Grants/Research Support Boheringer-Ingelheim Ekaterine Alexandris Full-time/part-time Employee Eli Lilly and Company Ekaterine Alexandris Stock Shareholder (directly Eli Lilly and Company purchased) Siraj Ali Full-time/part-time Employee Foundation Medicine Ash Alizadeh Consultant Roche Brian Allen Full-time/part-time Employee Myriad Genetics, Inc. Brian Allen Stock Shareholder (directly Myriad Genetics, Inc. purchased) Jared Allen Full-time/part-time Employee Oncimmune Ltd Justin Allen Full-time/part-time Employee Foundation Medicine Justin Allen Stock Shareholder (directly Foundation Medicine purchased) James Allison Consultant Bristol-Myers Squibb, Amgen, GlaxoSmithKline James Allison Honoraria Bristol-Myers Squibb James Allison Other (explain): Founder and advisor for Jounce Therapeutics James Allison Other (explain): Inventor of intellectual property owned by the University of California, Berkeley, and licensed to Bristol-Myers Squibb James Allison Other (explain): Member of the Parker Institute for Cancer Immunotherapy at M.D. Anderson Cancer Center Justyna Amelio Full-time/part-time Employee Amgen Justyna Amelio Stock Shareholder (directly Amgen purchased) Asim Amin Consultant BMS, Merck Asim Amin Grants/Research Support BMS, Merck, Prometheus, Akros Asim Amin Speakers Bureau BMS, Merck, Pfizer Kathy Amiri Full-time/part-time Employee Celgene (full-time) Kathy Amiri Stock Shareholder (directly Celgene purchased) Lukas Amler Full-time/part-time Employee Genentech Eunkyung An Full-time/part-time Employee Nantomics 2 Helen Angell Full-time/part-time Employee AstraZeneca Eric Angevin Honoraria MSD Lakshmanan Annamalai Full-time/part-time Employee Merck Sharp & Dohme (MSD) Peter Ansell Full-time/part-time Employee AbbVie Peter Ansell Stock Shareholder (directly AbbVie, may own stock purchased) Scott Antonia Consultant BMS, Merck, AZ, BI Scott Antonia Honoraria BMS, Merck, AZ, BI Scott Antonia Other (explain): (travel, accomodations, expenses): BMS, Merck, AZ, BI Scott Antonia Stock Shareholder (directly Cellular Biomedicine Group purchased) Kouji Aoyama Full-time/part-time Employee Astellas Pharma Inc. Francisco Aparisi Grants/Research Support ROCHE Andrea Ardizzoni Grants/Research Support Celgene Andrea Ardizzoni Honoraria BMS, MSD Andrea Ardizzoni Other (explain): Boehringer Ingelheim, Eli-Lilly (Advisory board) Andrea Ardizzoni Speakers Bureau Pfizer, Novartis Osvaldo Arén Honoraria BMS Allison Armour Full-time/part-time Employee Endocyte Lyle Arnold Full-time/part-time Employee Biocept Ashwini Arunachalam Other (explain): Fellow at Merck & Co Ryoichi Asabe Full-time/part-time Employee Chugai Pharma Takashi Asakawa Full-time/part-time Employee Genentech, Inc. Paolo Ascierto Consultant BMS, Roche-Genentech, MSD, Ventana, Novartis, Amgen, Array Paolo Ascierto Grants/Research Support BMS, Roche-Genentech, Ventana Jalal Assouad Consultant Covidien, Ethicon Shinji Atagi Grants/Research Support Chugai Pharmaceutical, Pfizer, Ono Pharmaceutical, Merck Serono, Boehringer Ingelheim, AstraZeneca, Taiho Pharmaceutical, Yakult Pharmaceutical Industry, Eli Lilly Shinji Atagi Speakers Bureau AstraZeneca, Taiho Pharmaceutical Thomas Atkinson Grants/Research Support NIH P30 CA08748-49 Akin Atmaca Consultant BMS Akin Atmaca Honoraria BMS Clarisse Audigier Valette Consultant Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, Novartis, PFIZER, Roche, Sysmex Clarisse Audigier Valette Grants/Research Support Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Roche Clarisse Audigier Valette Honoraria BMS Sandra Aung Full-time/part-time Employee UbiVac 3 Ricardo Avila Stock Shareholder (directly I am the founder and CEO of Accumetra, purchased) LLC. Accumetra develops phantoms and software to improve medical imaging decision making. Mark Awad Consultant Ariad, Bristol Myers Squibb, Clovis, Nektar Paul Baas Consultant Bristol-Myers Squibb, Merck, Celgene, Verastem Paul Baas Grants/Research Support Bristol-Myers Squibb, Merck Jeffrey Bacha Other (explain): DelMar Pharmaceuticals, Inc. Barbara Baggiani Full-time/part-time Employee Menarini Silicon Biosystems Isaac Bai Full-time/part-time Employee Roche Christina Baik Other (explain): Advisory board: Member of Clovis Oncology advisory board to discuss treatment practices in non-small lung cancer, therapy efficacy, and safety profiles, Flince Research & Design Bogdana Balas Full-time/part-time Employee F. Hoffmann-La Roche Bogdana Balas Stock Shareholder (directly F. Hoffmann-La Roche purchased) Marcus Ballinger Full-time/part-time Employee Genentech Marcus Ballinger Stock Shareholder (directly Genentech, Roche purchased) Udai Banerji Grants/Research Support AstraZeneca Kimberly Banks Full-time/part-time Employee Guardant Health, Inc. Kimberly Banks Other (explain): Employee with stock ownership in Guardant Health, Inc. Kimberly Banks Stock Shareholder (directly Guardant Health, Inc. purchased) Jair Bar Consultant BMS, MSD, Roche, Astra Zeneca Joaquina Baranda Full-time/part-time Employee Halozyme Lisa Barbarotta Speakers Bureau Celgene, BMS, Novartis Fabrice Barlesi Consultant AstraZeneca, BMS Fabrice Barlesi Grants/Research Support BMS, Roche, Genetech Fabrice Barlesi Honoraria AstraZeneca, BMS, Eli Lilly and Company, Novartis Fabrice Barlesi Other (explain): Advisory board or board of directors: Roche Michael Barnes Full-time/part-time Employee Roche Carlos Barrios Consultant Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Roche/Genentech, Eisai, Bioepis Carlos Barrios Grants/Research Support Pfizer, Novartis, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Taiho Pharmaceutical, Mylan, Merrimack, Merck, Abbvie, Astellas Pharma, Biomarin, Bristol-Myers Squibb, Daiichi Sankyo, Abraxis BioScience, AB Science, Asana Biosciences, Medivat Rich Barron Full-time/part-time Employee Amgen 4 Rich Barron Stock Shareholder (directly Amgen purchased) Jose Barrueco Full-time/part-time Employee Boehringer Ingelheim Rachael Barton Honoraria Pfizer Mickael Basson Full-time/part-time Employee Eli Lilly and Company Volker Baum Full-time/part-time Employee Novartis Lyudmila Bazhenova Consultant AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Clovis Oncology, Genoptix, Heat Biologics, Pfizer, Roche/Genentech, Seattle Genetics, and Trovagene Lyudmila Bazhenova Grants/Research Support AbbVie, ARIAD, Astellas, Astex, AstraZeneca/MedImmune,